Liraglutide Reduces BMI in Children, BridgeBio Halts Gene Therapy, Surge in Liver Disorder Cases, Vulcano's Surgery Offers Quick Relief, and more... episode artwork

EPISODE · Sep 11, 2024 · 11 MIN

Liraglutide Reduces BMI in Children, BridgeBio Halts Gene Therapy, Surge in Liver Disorder Cases, Vulcano's Surgery Offers Quick Relief, and more...

from Science News Daily · host brief.news

(0:10): Breakthrough Study: Liraglutide Significantly Reduces BMI in Young Children, Sparks Debate on Safety and Approval(2:09): BridgeBio Halts CAH Gene Therapy BBP-631, Shifts Focus to Promising Canavan Disease Treatment(4:35): Global Surge in Liver Disorder: MASLD Prevalence Could Hit 46% by 2030, Innovations in Food Therapy Offer Hope(6:48): Dr. Vulcano's Innovative Surgery Offers Rapid Relief for Achilles Tendinopathy Patients(8:53): Study Reveals Higher Chronic Pain Risk from Abdominal Fat in Women, Urges Targeted Weight ManagementTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: PerthNow

Episode metadata supplied by the publisher feed · Published Sep 11, 2024

Embed this episode

Ready to play

Liraglutide Reduces BMI in Children, BridgeBio Halts Gene Therapy, Surge in Liver Disorder Cases, Vulcano's Surgery Offers Quick Relief, and more...

0:00 11:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science News Daily?

This episode is 11 minutes long.

When was this Science News Daily episode published?

This episode was published on September 11, 2024.

Can I download this Science News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!